Search research articles
Contact Us
Filters
Showing results (31-40 of 91) with videos related to
Page
of 10
Sort By:
Urology
|
April 10, 2004
Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer
M Joerger, T Warzinek, B Klaeser, et al.
Oncology
|
December 28, 2007
Feasibility of using cetuximab and bevacizumab in a patient with colorectal cancer and terminal renal failure
R Inauen, R Cathomas, T Boehm, et al.
Chemotherapy
|
July 11, 2013
Management of elderly patients with advanced non-small cell lung cancer: a single-center experience
M Früh, H Besrour, S Gillessen, et al.
Cancer Research
|
February 24, 2001
Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation
T Teshima, N Mach, G R Hill, et al.
Blood
|
February 27, 2001
Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL
S Li, S Gillessen, M H Tomasson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 29, 2020
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C Parker, E Castro, K Fizazi, et al.
Neuroscience Letters
|
November 23, 1992
Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid
L B Laudiero, L Aloe, R Levi-Montalcini, et al.
ESMO Open
|
October 19, 2024
Androgen receptor pathway inhibitors and drug-drug interactions in prostate cancer
H Bolek, S C Yazgan, E Yekedüz, et al.
Annals of the New York Academy of Sciences
|
October 31, 1996
Evidence for multiple sites of interaction between IL-12 and its receptor
D H Presky, L J Minetti, S Gillessen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2019
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
B Escudier, C Porta, M Schmidinger, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 91) with videos related to
Sort By:
Page
of 10
Urology
|
April 10, 2004
Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer
M Joerger, T Warzinek, B Klaeser, et al.
Oncology
|
December 28, 2007
Feasibility of using cetuximab and bevacizumab in a patient with colorectal cancer and terminal renal failure
R Inauen, R Cathomas, T Boehm, et al.
Chemotherapy
|
July 11, 2013
Management of elderly patients with advanced non-small cell lung cancer: a single-center experience
M Früh, H Besrour, S Gillessen, et al.
Cancer Research
|
February 24, 2001
Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation
T Teshima, N Mach, G R Hill, et al.
Blood
|
February 27, 2001
Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL
S Li, S Gillessen, M H Tomasson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 29, 2020
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C Parker, E Castro, K Fizazi, et al.
Neuroscience Letters
|
November 23, 1992
Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid
L B Laudiero, L Aloe, R Levi-Montalcini, et al.
ESMO Open
|
October 19, 2024
Androgen receptor pathway inhibitors and drug-drug interactions in prostate cancer
H Bolek, S C Yazgan, E Yekedüz, et al.
Annals of the New York Academy of Sciences
|
October 31, 1996
Evidence for multiple sites of interaction between IL-12 and its receptor
D H Presky, L J Minetti, S Gillessen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2019
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
B Escudier, C Porta, M Schmidinger, et al.
Page
of 10